Diagnosis of common pulmonary diseases in children by X-ray images and deep learning

Advancements in imaging in ChILD

Interstitial and diffuse lung diseases in children constitute a range of congenital and acquired disorders. These disorders present with signs and symptoms of respiratory disease accompanied by diffuse radiographic changes. In many cases, radiographic findings are nonspecific, while in other disorders, chest computed tomography (CT) is diagnostic in the appropriate context. Regardless, chest imaging remains central in the evaluation of the patient with suspected childhood interstitial lung disease (chILD). Several newly described chILD entities, spanning both genetic and acquired etiologies, have imaging that aid in their diagnoses. Advances in CT scanning technology and CT analysis techniques continue to improve scan quality as well as expand use of chest CT as a research tool. Finally, ongoing research is expanding use of imaging modalities without ionizing radiation. Magnetic resonance imaging is being applied to investigate pulmonary structure and function, and ultrasound of the lung and pleura is a novel technique with an emerging role in chILD disorders. This review describes the current state of imaging in chILD including recently described diagnoses, advances in conventional imaging techniques and applications, and evolving new imaging modalities that expand the clinical and research roles for imaging in these disorders.

Applied artificial intelligence for global child health: Addressing biases and barriers

Given the potential benefits of artificial intelligence and machine learning (AI/ML) within healthcare, it is critical to consider how these technologies can be deployed in pediatric research and practice. Currently, healthcare AI/ML has not yet adapted to the specific technical considerations related to pediatric data nor adequately addressed the specific vulnerabilities of children and young people (CYP) in relation to AI. While the greatest burden of disease in CYP is firmly concentrated in lower and middle-income countries (LMICs), existing applied pediatric AI/ML efforts are concentrated in a small number of high-income countries (HICs). In LMICs, use-cases remain primarily in the proof-of-concept stage. This narrative review identifies a number of intersecting challenges that pose barriers to effective AI/ML for CYP globally and explores the shifts needed to make progress across multiple domains. Child-specific technical considerations throughout the AI/ML lifecycle have been largely overlooked thus far, yet these can be critical to model effectiveness. Governance concerns are paramount, with suitable national and international frameworks and guidance required to enable the safe and responsible deployment of advanced technologies impacting the care of CYP and using their data. An ambitious vision for child health demands that the potential benefits of AI/Ml are realized universally through greater international collaboration, capacity building, strong oversight, and ultimately diffusing the AI/ML locus of power to empower researchers and clinicians globally. In order that AI/ML systems that do not exacerbate inequalities in pediatric care, teams researching and developing these technologies in LMICs must ensure that AI/ML research is inclusive of the needs and concerns of CYP and their caregivers. A broad, interdisciplinary, and human-centered approach to AI/ML is essential for developing tools for healthcare workers delivering care, such that the creation and deployment of ML is grounded in local systems, cultures, and clinical practice. Decisions to invest in developing and testing pediatric AI/ML in resource-constrained settings must always be part of a broader evaluation of the overall needs of a healthcare system, considering the critical building blocks underpinning effective, sustainable, and cost-efficient healthcare delivery for CYP.

Artificial Intelligence in Pediatrics: Learning to Walk Together

In this era of rapidly advancing technology, artificial intelligence (AI) has emerged as a transformative force, even being called the Fourth Industrial Revolution, along with gene editing and robotics. While it has undoubtedly become an increasingly important part of our daily lives, it must be recognized that it is not an additional tool, but rather a complex concept that poses a variety of challenges. AI, with considerable potential, has found its place in both medical care and clinical research. Within the vast field of pediatrics, it stands out as a particularly promising advancement. As pediatricians, we are indeed witnessing the impactful integration of AI-based applications into our daily clinical practice and research efforts. These tools are being used for simple to more complex tasks such as diagnosing clinically challenging conditions, predicting disease outcomes, creating treatment plans, educating both patients and healthcare professionals, and generating accurate medical records or scientific papers. In conclusion, the multifaceted applications of AI in pediatrics will increase efficiency and improve the quality of healthcare and research. However, there are certain risks and threats accompanying this advancement including the biases that may contribute to health disparities and, inaccuracies. Therefore, it is crucial to recognize and address the technical, ethical, and legal challenges as well as explore the benefits in both clinical and research fields.

Artificial Intelligence in Paediatric Tuberculosis

Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the "End TB Strategy" and framework set out by the World Health Organization (WHO). Since the inception of artificial intelligence (AI) more than 60 years ago, the interest in AI has risen and more recently we have seen the emergence of multiple real-world applications, many of which relate to medical imaging. Nonetheless, real-world AI applications and clinical studies are limited in the niche area of paediatric imaging. This review article will focus on how AI, or more specifically deep learning, can be applied to TB diagnosis and management in children. We describe how deep learning can be utilised in chest imaging to provide computer-assisted diagnosis to augment workflow and screening efforts. We also review examples of recent AI applications for TB screening in resource constrained environments and we explore some of the challenges and the future directions of AI in paediatric TB.

Pediatrics in Artificial Intelligence Era: A Systematic Review on Challenges, Opportunities, and Explainability

BACKGROUND

The emergence of artificial intelligence (AI) tools such as ChatGPT and Bard is disrupting a broad swathe of fields, including medicine. In pediatric medicine, AI is also increasingly being used across multiple subspecialties. However, the practical application of AI still faces a number of key challenges. Consequently, there is a requirement for a concise overview of the roles of AI across the multiple domains of pediatric medicine, which the current study seeks to address.

AIM

To systematically assess the challenges, opportunities, and explainability of AI in pediatric medicine.

METHODOLOGY

A systematic search was carried out on peer-reviewed databases, PubMed Central, Europe PubMed Central, and grey literature using search terms related to machine learning (ML) and AI for the years 2016 to 2022 in the English language. A total of 210 articles were retrieved that were screened with PRISMA for abstract, year, language, context, and proximal relevance to research aims. A thematic analysis was carried out to extract findings from the included studies.

RESULTS

Twenty articles were selected for data abstraction and analysis, with three consistent themes emerging from these articles. In particular, eleven articles address the current state-of-the-art application of AI in diagnosing and predicting health conditions such as behavioral and mental health, cancer, syndromic and metabolic diseases. Five articles highlight the specific challenges of AI deployment in pediatric medicines: data security, handling, authentication, and validation. Four articles set out future opportunities for AI to be adapted: the incorporation of Big Data, cloud computing, precision medicine, and clinical decision support systems. These studies collectively critically evaluate the potential of AI in overcoming current barriers to adoption.

CONCLUSION

AI is proving disruptive within pediatric medicine and is presently associated with challenges, opportunities, and the need for explainability. AI should be viewed as a tool to enhance and support clinical decision-making rather than a substitute for human judgement and expertise. Future research should consequently focus on obtaining comprehensive data to ensure the generalizability of research findings.

Deep learning for pneumothorax diagnosis: a systematic review and meta-analysis

BACKGROUND

Deep learning (DL), a subset of artificial intelligence (AI), has been applied to pneumothorax diagnosis to aid physician diagnosis, but no meta-analysis has been performed.

METHODS

A search of multiple electronic databases through September 2022 was performed to identify studies that applied DL for pneumothorax diagnosis using imaging. Meta-analysis via a hierarchical model to calculate the summary area under the curve (AUC) and pooled sensitivity and specificity for both DL and physicians was performed. Risk of bias was assessed using a modified Prediction Model Study Risk of Bias Assessment Tool.

RESULTS

In 56 of the 63 primary studies, pneumothorax was identified from chest radiography. The total AUC was 0.97 (95% CI 0.96-0.98) for both DL and physicians. The total pooled sensitivity was 84% (95% CI 79-89%) for DL and 85% (95% CI 73-92%) for physicians and the pooled specificity was 96% (95% CI 94-98%) for DL and 98% (95% CI 95-99%) for physicians. More than half of the original studies (57%) had a high risk of bias.

CONCLUSIONS

Our review found the diagnostic performance of DL models was similar to that of physicians, although the majority of studies had a high risk of bias. Further pneumothorax AI research is needed.

Data harnessing to nurture the human mind for a tailored approach to the child

Big data in pediatrics is an ocean of structured and unstructured data. Big data analysis helps to dive into the ocean of data to filter out information that can guide pediatricians in their decision making, precision diagnosis, and targeted therapy. In addition, big data and its analysis have helped in the surveillance, prevention, and performance of the health system. There has been a considerable amount of work in pediatrics that we have tried to highlight in this review and some of it has been already incorporated into the health system. Work in specialties of pediatrics is still forthcoming with the creation of a common data model and amalgamation of the huge "omics" database. The physicians entrusted with the care of children must be aware of the outcome so that they can play a role to ensure that big data algorithms have a clinically relevant effect in improving the health of their patients. They will apply the outcome of big data and its analysis in patient care through clinical algorithms or with the help of embedded clinical support alerts from the electronic medical records. IMPACT: Big data in pediatrics include structured, unstructured data, waveform data, biological, and social data. Big data analytics has unraveled significant information from these databases. This is changing how pediatricians will look at the body of available evidence and translate it into their clinical practice. Data harnessed so far is implemented in certain fields while in others it is in the process of development to become a clinical adjunct to the physician. Common databases are being prepared for future work. Diagnostic and prediction models when incorporated into the health system will guide the pediatrician to a targeted approach to diagnosis and therapy.

Prediction of Bronchopneumonia Inpatients' Total Hospitalization Expenses Based on BP Neural Network and Support Vector Machine Models

Objective

BP neural network (BPNN) model and support vector machine (SVM) model were used to predict the total hospitalization expenses of patients with bronchopneumonia.

Methods

A total of 355 patients with bronchopneumonia from January 2018 to December 2020 were collected and sorted out. The data set was randomly divided into a training set (n = 249) and a test set (n = 106) according to 7 : 3. The BPNN model and SVM model were constructed to analyze the predictors of total hospitalization expenses. The effectiveness was compared between these two prediction models.

Results

The top three influencing factors and their importance for predicting total hospitalization cost by the BPNN model were hospitalization days (0.477), age (0.154), and discharge department (0.083). The top 3 factors predicted by the SVM model were hospitalization days (0.215), age (0.196), and marital status (0.172). The area under the curve of these two models is 0.838 (95% CI: 0.755~0.921) and 0.889 (95% CI: 0.819~0.959), respectively.

Conclusion

Both the BPNN model and SVM model can predict the total hospitalization expenses of patients with bronchopneumonia, but the prediction effect of the SVM model is better than the BPNN model.

Towards Accurate Point-of-Care Tests for Tuberculosis in Children

In childhood tuberculosis (TB), with an estimated 69% of missed cases in children under 5 years of age, the case detection gap is larger than in other age groups, mainly due to its paucibacillary nature and children’s difficulties in delivering sputum specimens. Accurate and accessible point-of-care tests (POCTs) are needed to detect TB disease in children and, in turn, reduce TB-related morbidity and mortality in this vulnerable population. In recent years, several POCTs for TB have been developed. These include new tools to improve the detection of TB in respiratory and gastric samples, such as molecular detection of Mycobacterium tuberculosis using loop-mediated isothermal amplification (LAMP) and portable polymerase chain reaction (PCR)-based GeneXpert. In addition, the urine-based detection of lipoarabinomannan (LAM), as well as imaging modalities through point-of-care ultrasonography (POCUS), are currently the POCTs in use. Further to this, artificial intelligence-based interpretation of ultrasound imaging and radiography is now integrated into computer-aided detection products. In the future, portable radiography may become more widely available, and robotics-supported ultrasound imaging is currently being trialed. Finally, novel blood-based tests evaluating the immune response using “omic-“techniques are underway. This approach, including transcriptomics, metabolomic, proteomics, lipidomics and genomics, is still distant from being translated into POCT formats, but the digital development may rapidly enhance innovation in this field. Despite these significant advances, TB-POCT development and implementation remains challenged by the lack of standard ways to access non-sputum-based samples, the need to differentiate TB infection from disease and to gain acceptance for novel testing strategies specific to the conditions and settings of use.

Current and emerging artificial intelligence applications in chest imaging: a pediatric perspective

Artificial intelligence (AI) applications for chest radiography and chest CT are among the most developed applications in radiology. More than 40 certified AI products are available for chest radiography or chest CT. These AI products cover a wide range of abnormalities, including pneumonia, pneumothorax and lung cancer. Most applications are aimed at detecting disease, complemented by products that characterize or quantify tissue. At present, none of the thoracic AI products is specifically designed for the pediatric population. However, some products developed to detect tuberculosis in adults are also applicable to children. Software is under development to detect early changes of cystic fibrosis on chest CT, which could be an interesting application for pediatric radiology. In this review, we give an overview of current AI products in thoracic radiology and cover recent literature about AI in chest radiography, with a focus on pediatric radiology. We also discuss possible pediatric applications.

Artificial intelligence in paediatric radiology: international survey of health care professionals' opinions

BACKGROUND

The nature of paediatric radiology work poses several challenges for developing and implementing artificial intelligence (AI) tools, but opinions of those working in the field are currently unknown.

OBJECTIVE

To evaluate the attitudes and perceptions toward AI amongst health care professionals working within children's imaging services.

MATERIALS AND METHODS

A web-based questionnaire was distributed to the membership of several paediatric and general radiological societies over a 4-month period (1 Feb - 31 May 2020). Survey questions covered attitudes toward AI in general, future impacts and suggested areas for development specifically within paediatric imaging.

RESULTS

Two hundred and forty responses were collected with the majority being from radiologists (159/240, 66.3%; 95% confidence interval [CI] 59.8-72.2%) or allied health care professionals (72/240, 31.3%; 95% CI 25.4-37.5%). Respondents agreed that AI could potentially alert radiologists to imaging abnormalities (148/240, 61.7%; 95% CI 55.2-67.9%) but preferred that results were checked by a human (200/240, 83.3%; 95% CI 78.0-87.8%). The majority did not believe jobs in paediatric radiology would be replaced by AI (205/240, 85.4%; 95% CI 80.3-89.6%) and that the development of AI tools should focus on improved diagnostic accuracy (77/240, 32.1%; 95% CI 26.2-38.4%), workflow efficiencies (60/240, 25.0%; 95% CI 19.7-30.9%) and patient safety (54/240, 22.5%; 95% CI 17.4-28.3%). The majority of European Society of Paediatric Radiology (ESPR) members (67/81, 82.7%; 95% CI 72.7-90.2%) welcomed the idea of a dedicated paediatric radiology AI task force with emphasis on educational events and anonymised dataset curation.

CONCLUSION

Imaging health care professionals working with children had a positive outlook regarding the use of AI in paediatric radiology, and did not feel their jobs were threatened. Future AI tools would be most beneficial for easily automated tasks and most practitioners welcomed the opportunity for further AI educational activities.

MARnet: multi-scale adaptive residual neural network for chest X-ray images recognition of lung diseases

Chest X-ray image is an important clinical diagnostic reference to lung diseases that is a serious threat to human health. At present, with the rapid development of computer vision and deep learning technology, many scholars have carried out the fruitful research on how to build a valid model for chest X-ray images recognition of lung diseases. While some efforts are still expected to improve the performance of the recognition model and enhance the interpretability of the recognition results. In this paper, we construct a multi-scale adaptive residual neural network (MARnet) to identify chest X-ray images of lung diseases. To make the model better extract image features, we cross-transfer the information extracted by residual block and the information extracted by adaptive structure to different layer, avoiding the reduction effect of residual structure on adaptive function. We compare MARnet with some classical neural networks, and the results show that MARnet achieves accuracy (ACC) of 83.3% and the area under ROC curve (AUC) of 0.97 in the identification of 4 kinds of typical lung X-ray images including nodules, atelectasis, normal and infection, which are higher than those of other methods. Moreover, to avoid the randomness of the train-test-split method, 5-fold cross-validation method is used to verify the generalization ability of the MARnet model and the results are satisfactory. Finally, the technique called Gradient-weighted Class Activation Mapping (Grad-CAM), is adopted to display significantly the discriminative regions of the images in the form of the heat map, which provides an explainable and more direct clinical diagnostic reference to lung diseases.

Pediatric quality measures: The leap from process to outcomes

Value-based reimbursement arrangements tie financial incentives to achieving quality measures to ensure savings are not from withholding care. For patients and their families, the delivery of high-quality care is simply the expectation. Defining and measuring pediatric quality, however, is not standardized which has led to a large proliferation of metrics across multiple stakeholders. The majority of these measures are process rather than outcomes metrics often chosen for the ease at which the data can be obtained. In order to drive greater value, outcomes measures should be preferentially selected. However, measuring outcomes in children presents multiple unique challenges. Compared to adults, children are generally healthier, their outcomes may take more time to manifest, and their clinical variability is greater. Another challenge is the amount of healthcare data being generated by providers, provider networks, payors, government agencies, and many others. This should help in understanding pediatric quality outcomes, but the massive volume of data requires new analytic tools. Artificial intelligence techniques such as machine learning offer faster, more precise, and larger scale evaluation of quality outcomes. Its implementation necessitates identifying expertise in the way of data scientists as well as additional infrastructure components to evaluate data governance, security, regulatory compliance, and ethics. Despite these prerequisites, much progress is being made in outcome insights that drive value benefiting children and families.

Deep learning for chest X-ray analysis: A survey

Recent advances in deep learning have led to a promising performance in many medical image analysis tasks. As the most commonly performed radiological exam, chest radiographs are a particularly important modality for which a variety of applications have been researched. The release of multiple, large, publicly available chest X-ray datasets in recent years has encouraged research interest and boosted the number of publications. In this paper, we review all studies using deep learning on chest radiographs published before March 2021, categorizing works by task: image-level prediction (classification and regression), segmentation, localization, image generation and domain adaptation. Detailed descriptions of all publicly available datasets are included and commercial systems in the field are described. A comprehensive discussion of the current state of the art is provided, including caveats on the use of public datasets, the requirements of clinically useful systems and gaps in the current literature.

Inter-rater reliability in quality assurance (QA) of pediatric chest X-rays

PURPOSE

The goal of the study is to determine the inter-rater agreement on multiple factors that were utilized to evaluate the quality of pediatric chest X-ray exams from different levels of healthcare provision in an African setting.

METHODS

The image quality of pediatric chest X-rays from 3 South African medical centers of varying level of healthcare service were retrospectively assessed by 3 raters for 12 quality factors including: (1) absent body parts; (2) under inspiration; (3) patient rotation; (4) scapula in the way; (5) patient kyphosis/lordosis; (6) artefact/foreign body; (7) central vessel visualization; (8) peripheral vessels visualization; (9) poor collimation; and (10) trachea and bronchi visualization; (11) post-cardiac vessel visualization; and (12) absent or wrong image orientation. Analysis was performed using the Brennan--Prediger coefficient of agreement for inter-rater reliability and Cochran's Q statistic and McNemar's test for inter-rater bias.

RESULTS

1077 X-rays were reviewed. The least difference between observers in the frequency of the errors was noticed for factors (1) absent body parts and (12) absent or wrong image orientation with almost perfect agreement between raters. κ score for these two factors among all raters and between each pair of raters was more than 0.95 with no significant inter-rater bias. Conversely, there was poor agreement for the remaining factors with the least agreed on being factor (3) patient rotation with a κ score of 0.23. This was followed by factors (2) under inspiration (κ score of 0.32) and factors (4) scapula in the way (κ score of 0.35) respectively. There was significant inter-rater bias for all these three factors.

CONCLUSION

Many of the factors used to assess the quality of a chest X-ray in children demonstrate poor reliability despite mitigation against variations in training, standard quality definitions and level of healthcare service provision. New definitions, objective measures and recording tools for assessing pediatric chest radiographic quality are required.